Navigation Links
SCAI Opposes U.S. House of Representatives Health Reform Bill in Current Form
Date:7/28/2009

ractice insurance

We are concerned that this bill in its current form fails to address both the short- and long-term issues with the health care system. SCAI is strongly supportive of health reform legislation that allows all patients to have access to the most contemporary cardiovascular therapies, where the doctor and patient can work together to determine a most appropriate treatment plan and doctors can deliver the best possible outcomes for patients depending on their individual goals and lifestyles.

SCAI believes comparative effectiveness research is an important component of health care reform but warns against substituting a system that could evolve into one that evaluates treatment options on costs for one that rewards quality of care. To the contrary, SCAI supports a care model that allows doctors to individualize care to optimally meet each patient's unique medical needs.

SCAI supports health care reform and access for all Americans but is concerned that major advances in cardiovascular care will be hindered by the current approach to reform.

SCAI's letter to Congress provides additional detail on the Society's position and is available at http://www.scai.org/pdf/2009July23HealthCareReform.pdf

About SCAI

The mission of the Society for Cardiovascular Angiography and Interventions (SCAI) is to promote excellence in invasive and interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. SCAI's patient and physician education program, Seconds Count, offers comprehensive information about cardiovascular disease. For more information about SCAI and Seconds Count, vis
'/>"/>

SOURCE SCAI
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. PIA Opposes Kennedy Proposal to Create Health Insurance "Navigators"
2. Veterinary Group Opposes Bill to Clean Up Puppy Mill Industry
3. Local Medical Association Opposes Two State Propositions
4. Physician Group Opposes FDA's Position on Adult Stem Cells
5. Association for Healthcare Philanthropy Opposes Limits on Charitable Tax Deductions
6. Consumer Watchdog to U.S. Senate: Dont Leave Consumers Out of Health Reform Debate, Public Opposes Mandatory Purchases of Private Insurance & Supports Opening Medicare to Everyone
7. AVMA Opposes Use of Double-Deck Trailers for Transporting Horses and Other Equines
8. Michigan Chamber of Commerce Opposes Blank Check Healthcare Ballot Proposal
9. Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
10. FTC Opposes Collective Bargaining for Providers in Puerto Rico
11. Consumers Union Opposes Over-the-Counter Cholesterol Drug
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 2Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 3Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 4Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 5Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 6Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 7Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 8Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 9Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 10Health News:Fish Really May Be Brain Food 2Health News:DeviceSpace Career Fair Opens Doors for Hundreds of Medical Device and Diagnostics Career Candidates 2Health News:Is Mom or Dad Safe to Live Alone? 2Health News:SpectraScience Acquires Luma Imaging Corporation 2Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 2Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 3Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 4Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 5
Breaking Medicine Technology:NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5Health Insurance Options for Domestic Partnerships 51188 1Health Insurance Options for Domestic Partnerships 51188 2Health Insurance Options for Domestic Partnerships 51188 3Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 1Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 2Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 3Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 4Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 5Statement by Registered Dietitian and American Dietetic Association President Jessie M Pavlinac on Health Reform and Conservation of Natural Resource 51184 1Statement by Registered Dietitian and American Dietetic Association President Jessie M Pavlinac on Health Reform and Conservation of Natural Resource 51184 2